Related references
Note: Only part of the references are listed.Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients
Malcolm A. Gleser et al.
INTERNATIONAL JOURNAL OF AUDIOLOGY (2018)
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis
Angela C. Garinis et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review
Debora T. M. Caumo et al.
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY (2017)
High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis
Ghada Al-Malky et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
The Tinnitus Functional Index: Development of a New Clinical Measure for Chronic, Intrusive Tinnitus
Mary B. Meikle et al.
EAR AND HEARING (2012)
Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions
Ghada Al-Malky et al.
INTERNATIONAL JOURNAL OF AUDIOLOGY (2011)
No hearing loss after repeated courses of tobramycin in cystic fibrosis patients
Renske J. Scheenstra et al.
ACTA OTO-LARYNGOLOGICA (2010)
Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients
Michael Mulheran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Use of 35 words for evaluation of hearing loss in signal-to-babble ratio: A clinic protocol
Richard H. Wilson et al.
JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT (2005)
Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness
L Yardley et al.
ANNALS OF INTERNAL MEDICINE (2004)
Share Paper
